Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

NCT02636036

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +21 more
Locations
  • University of Arizona Cancer Center, 1515 North Campbell Ave. Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center, 1500 E Duarte Str. Duarte, California, United States
  • UCLA Medical Center, 10945 Le Conte Ave, Ste. 3360 Santa Monica, California, United States
  • Horizon Oncology Research, 1345 Unity Place, Suite 365 Lafayette, Indiana, United States
View Trial Details
Completed

CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer

NCT02052960

Conditions
Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck, +6 more
Locations
  • Glycotope-contracted Research Facility Antwerp, Belgium
  • Glycotope-contracted Research Facility Brussels, Belgium
  • Glycotope-contracted Research Facility Brussels, Belgium
  • Glycotope-contracted Research Facility Ghent, Belgium
View all 34 locations
View Trial Details
Completed

NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)

NCT01950689

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Cheltenham General Hospital Cheltenham, Gloucestershire, United Kingdom
  • Clatterbridge Centre for Oncology Bebington, Merseyside, United Kingdom
  • St James' Hospital Leeds, West Yorkshire, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
View all 21 locations
View Trial Details
Completed

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

NCT02551159

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site St. Petersburg, Florida, United States
View all 197 locations
View Trial Details
Completed

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

NCT01353625

Conditions
Astrocytoma, Blood Protein Disorders, Carcinoma, +52 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

NCT00381706

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 227 locations
View Trial Details

Related conditions